**Core Concept**
Buspirone is a non-benzodiazepine anxiolytic agent that primarily acts on serotonin receptors, specifically the 5-HT1A subtype. This action is distinct from the mechanism of traditional benzodiazepines, which modulate the activity of GABA (gamma-aminobutyric acid) in the brain.

**Why the Correct Answer is Right**
Buspirone's unique mechanism of action results in anxiolytic effects with minimal sedation. Unlike benzodiazepines, which enhance the activity of GABA, buspirone does not significantly affect GABA receptors. Instead, it selectively binds to 5-HT1A receptors, leading to a reduction in anxiety symptoms without causing significant sedation or impairment of cognitive function. This selective action is beneficial in treating anxiety disorders without the drawbacks associated with traditional anxiolytics.

**Why Each Wrong Option is Incorrect**
**Option B:** Triazolam is a short-acting benzodiazepine with potent sedative and anxiolytic effects, but it is not known for its selectivity and can cause significant sedation, making it a poor choice for patients requiring anxiolytic action with minimal sedation.
**Option C:** Alprazolam is another benzodiazepine with anxiolytic and sedative properties, but its mechanism of action, like other benzodiazepines, is not selective and can lead to significant sedation.
**Option D:** Chlordiazepoxide is a classic benzodiazepine with anxiolytic and sedative effects, but it also lacks selectivity and can cause significant sedation, making it an unsuitable choice for patients requiring anxiolytic action with minimal sedation.

**Clinical Pearl / High-Yield Fact**
Buspirone's unique mechanism of action is due to its selective binding to 5-HT1A receptors, which is distinct from the GABA-modulating mechanism of traditional benzodiazepines. This selective action allows buspirone to provide anxiolytic effects without significant sedation, making it a valuable treatment option for patients with anxiety disorders.

**✓ Correct Answer: A. Buspirone**